Tuesday saw a good slate of deals, including the acceleration of Ohio's $508.865 million of GOs and Austin's $419.035 million ...

Assured Guaranty commented on Brightline and PREPA during its third-quarter earnings call, on which the company reported a 46 ...

Oral presentation of GLPG5101 data from the ATALANTA-1 study in patients with high-risk relapsed/refractory mantle cell lymphoma Two abstracts ...

Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.

LONDON and GAITHERSBURG, Md., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering ...

For patients across all indications treated within the RP2D range early, promising progression-free survival (PFS) and ...

The demand for the gum rosin is driven by its widespread use in industries such as adhesives, rubber, inks, and coatings, offering natural, biodegradable, ...

About Safusidenib Safusidenib is a novel, oral, potent, brain-penetrant, targeted inhibitor of mutant IDH1. In a Phase 1 clinical study, safusidenib was well-tolerated and demonstrated anti-tumor ...

MonotaRO, the Japanese business-to-business (B2B) e-commerce platform, was the largest detractor during the quarter. Read more here.

A segment of ultra-fast fashion moves products from design to market within days, releases thousands of new items weekly, and ...

2025 Mineral Resource Estimate (“MRE”) incorporates a 312% increase in Measured plus Indicated Mineral Resources, at a cut-off grade of 0.1% Cu and a net smelter return (“NSR”) cut-off value of ...